Publications by authors named "Stephen Esker"

Claim this Profile
H
HER2 and HER3 expression during neoadjuvant treatment of HER2-negative early breast cancer: potential for biomarker-driven sequencing of T-DXd and HER3-DXd.
Christian Fridolin Singer, Stephan Wenzel Jahn, Dominik Hlauschek, Ulrike Maria Heber, Charlotte Mang-Manger, Stephen Esker

Cancer Commun (Lond)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy.
Jyoti Patel, Jie Meng, Hoa Le, Yoko Tanaka, Sudarshan Phani, Stephen Esker

Adv Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response.
Fara Brasó-Maristany, Juan Manuel Ferrero-Cafiero, Claudette Falato, Olga Martínez-Sáez, Juan Miguel Cejalvo, Stephen Esker

Nat Commun· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced -mutated NSCLC after a third-generation EGFR TKI.
Tony Mok, Pasi A Jänne, Makoto Nishio, Silvia Novello, Martin Reck, Stephen Esker

Future Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review.
Mustafa Khasraw, Priyanka Yalamanchili, Anu Santhanagopal, Chuntao Wu, Maribel Salas, Stephen Esker

Adv Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer.
Tomás Pascual, Mafalda Oliveira, Eva Ciruelos, Meritxell Bellet Ezquerra, Cristina Saura, Stephen Esker

Front Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Care Costs in a Cohort of HIV-Infected U.S. Veterans Receiving Regimens Containing Tenofovir Disoproxil Fumarate/Emtricitabine.
Richard E Nelson, Junjie Ma, Jacob Crook, Kristin Knippenberg, Heather Nyman, Stephen Esker

J Manag Care Spec Pharm· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals.
Joanne LaFleur, Adam P Bress, Joel Myers, Lisa Rosenblatt, Jacob Crook, Stephen Esker

Infect Dis Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: Tenofovir-Associated Nephrotoxicity Among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals.
Joanne LaFleur, Adam P Bress, Stephen Esker, Kristin Knippenberg, Jacob Crook

J Acquir Immune Defic Syndr· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative incidence and health care costs of medically attended adverse effects among U.S. Medicaid HIV patients on atazanavir- or darunavir-based antiretroviral therapy.
Stephen S Johnston, Timothy Juday, Stephen Esker, Derek Espindle, Bong-Chul Chu

Value Health· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring the risk of birth defects associated with atazanavir exposure in pregnancy.
Stephen Esker, Jessica Albano, Jonathan Uy, Dilek Arikan, Maria Jesus Jimenez-Exposito

AIDS Patient Care STDS· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in virologically suppressed, HIV-1-Infected subjects after switching to a simplified, single-tablet regimen of efavirenz, emtricitabine, and tenofovir DF.
Sally L Hodder, Karam Mounzer, Edwin Dejesus, Ramin Ebrahimi, Kristy Grimm, Stephen Esker

AIDS Patient Care STDS· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis